Abstract Introduction Malignant pleural effusion (MPE) occurs in up to 30% of lung cancer patients and is primarily managed for palliation. While procedural safety of thoracentesis and indwelling catheter drainage is well established, catastrophic hemorrhage remains exceedingly rare. We report a fatal post-drainage pulmonary hemorrhage in a patient with post-radiation non-small-cell lung carcinoma (NSCLC), proposing the novel hypothesis that pleural effusion may act as a physiologic “tamponade,” limiting tumor vessel rupture. Case Presentation A 49-year-old man with stage IIIB right lower-lobe NSCLC (adenocarcinoma, PD-L1 TPS 5%) previously treated with concurrent chemoradiation presented with recurrent dyspnea and pleural effusion. Imaging showed a partially regressed necrotic mass adjacent to moderate effusion without new vascular invasion. Diagnostic thoracentesis removed 1 L of exudative fluid positive for malignant cells; symptoms improved but effusion re-accumulated within 24 hours. A tunneled pleural catheter (PleurX) was inserted and 850 mL drained uneventfully. Eighteen hours later, the patient developed sudden massive hemoptysis and cardiopulmonary collapse. Despite full resuscitation, death ensued. Laboratory studies showed no coagulopathy or thrombocytopenia, and imaging revealed no procedural injury. The event was attributed to tumor-related vascular rupture likely precipitated by decompression. Discussion This case highlights a paradox: a clinically stable, regressing tumor complicated by fatal bleeding following fluid evacuation. The temporal association suggests a physiologic mechanism—loss of hydrostatic counter-pressure (“tamponade”) exerted by pleural fluid on necrotic, friable tumor vessels. Rapid pressure reduction may have increased transmural vascular tension, analogous to re-expansion pulmonary edema dynamics, causing vessel rupture. Literature review identified fewer than ten reported cases of hemorrhage after pleural drainage in thoracic malignancy. Shared features included post-radiation necrosis, cavitary tumors, and abrupt decompression. Recognition of this mechanism has important clinical implications: manometry-guided, symptom-limited drainage and heightened vigilance for sentinel hemoptysis could mitigate risk. Novelty/Importance To our knowledge, this is the first report explicitly proposing the pleural tamponade hypothesis in thoracic oncology. It reframes MPE not only as a pathologic by-product but also as a potential biomechanical stabilizer—underscoring the need for physiologic modeling of pleural pressure-vascular interactions in necrotic lung tumors. This abstract is funded by: None
Kumar et al. (Fri,) studied this question.